These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23656459)

  • 1. HAART has no major impact on hematological and plasma bilirubin changes in HIV-infected patients with congenital G-6-PD deficiency.
    Pornprasert S; Panya A; Cheepsunthorn CL; Srithep S; Kingkeow D
    Curr HIV Res; 2013 Apr; 11(3):193-7. PubMed ID: 23656459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of hematological parameters in HIV-1-infected patients with and without thalassemia carriages during highly active antiretroviral therapy.
    Pornprasert S; Sonboon P; Kiatwattanacharoen S; Klinbuayaem V; Leenasirimakul P; Promping C; Inta P; Ajhan S; Leechanachai P
    HIV Clin Trials; 2009; 10(2):88-93. PubMed ID: 19487178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of antiretroviral drugs for prevention of HIV-mother-to-child transmission on hematological parameters and hemoglobin synthesis in HIV-uninfected newborns with and without thalassemia carrier.
    Wongnoi R; Oberdorfer P; Sirivatanapa P; Phanpong C; Pornprasert S
    Curr HIV Res; 2013 Apr; 11(3):187-92. PubMed ID: 23607655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anemia in patients with coinherited thalassemia and glucose-6-phosphate dehydrogenase deficiency.
    Pornprasert S; Phanthong S
    Hemoglobin; 2013; 37(6):536-43. PubMed ID: 23944358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anemia in HIV-infected patients receiving highly active antiretroviral therapy.
    Moore RD; Forney D
    J Acquir Immune Defic Syndr; 2002 Jan; 29(1):54-7. PubMed ID: 11782590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of incidence of zidovudine induced anemia in Indian human immunodeficiency virus positive patients in comparison with stavudine based highly active antiretroviral therapy.
    Rajesh R; Vidyasagar S; Varma DM; Mohiuddin S; Noorunnisa
    Int J Risk Saf Med; 2011; 23(3):171-80. PubMed ID: 22020397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era.
    Kallianpur AR; Wang Q; Jia P; Hulgan T; Zhao Z; Letendre SL; Ellis RJ; Heaton RK; Franklin DR; Barnholtz-Sloan J; Collier AC; Marra CM; Clifford DB; Gelman BB; McArthur JC; Morgello S; Simpson DM; McCutchan JA; Grant I;
    J Infect Dis; 2016 Apr; 213(7):1065-73. PubMed ID: 26690344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of highly active antiretroviral therapy (HAART) and hepatitis C Co-infection on hyperlipidemia in HIV-infected patients: a retrospective longitudinal study.
    Patroni A; Torti C; Tomasoni L; Quiros Roldan E; Bertelli D; Puoti M; Cadeo GP; Sleiman I; Tinelli C; Carosi G; Castelli F
    HIV Clin Trials; 2002; 3(6):451-61. PubMed ID: 12501128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of highly active antiretroviral therapy (HAART) of stavudine, lamivudine and nevirapine on the CD4 lymphocyte count of HIV-infected Africans: the Nigerian experience.
    Erhabor O; Ejele OA; Nwauche CA
    Niger J Clin Pract; 2006 Dec; 9(2):128-33. PubMed ID: 17319344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Impact of antiretroviral therapy on occurrences of macrocytosis in patients with HIV/AIDS in Maringá, State of Paraná].
    Oliveira OC; Oliveira RA; Souza Ldo R
    Rev Soc Bras Med Trop; 2011; 44(1):35-9. PubMed ID: 21340405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilirubin conjugation, reflected by conjugated bilirubin fractions, in glucose-6-phosphate dehydrogenase-deficient neonates: a determining factor in the pathogenesis of hyperbilirubinemia.
    Kaplan M; Muraca M; Hammerman C; Vilei MT; Leiter C; Rudensky B; Rubaltelli FF
    Pediatrics; 1998 Sep; 102(3):E37. PubMed ID: 9724685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of highly active antiretroviral therapy in Indian human immunodeficiency virus positive patients.
    Rajesh R; Vidyasagar S; Varma DM; Naik A; Hegde BM; Guddattu V; Kamath A
    Int J Risk Saf Med; 2013 Jan; 25(1):53-65. PubMed ID: 23442298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymic Function during 12 Months of Highly Active Antiretroviral Therapy in Thai HIV-Infected Patients with Normal and Slow Immune Recovery.
    Kingkeow D; Srithep S; Praparattanapan J; Supparatpinyo K; Pornprasert S
    Jpn J Infect Dis; 2015; 68(5):353-6. PubMed ID: 25720642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of mean corpuscular volume (MCV) between thalassemia-carrier and non-thalassemia-carrier pregnant women receiving highly active antiretroviral therapy (HAART).
    Thongyou Y; Tongprasert F
    Taiwan J Obstet Gynecol; 2017 Dec; 56(6):736-739. PubMed ID: 29241911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Anemia and Immunological Markers in HIV-Infected Patients on Highly Active Antiretroviral Therapy in Northeastern Nigeria.
    Denue BA; Kida IM; Hammagabdo A; Dayar A; Sahabi MA
    Infect Dis (Auckl); 2013; 6():25-33. PubMed ID: 24847174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in antioxidant profile among HIV-infected individuals on generic highly active antiretroviral therapy in southern India.
    Sundaram M; Saghayam S; Priya B; Venkatesh KK; Balakrishnan P; Shankar EM; Murugavel KG; Solomon S; Kumarasamy N
    Int J Infect Dis; 2008 Nov; 12(6):e61-6. PubMed ID: 18621564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of baseline CD4(+) T cell counts on the efficacy of nevirapine-based highly active antiretroviral therapy in Chinese HIV/AIDS patients: a prospective, multicentric study.
    Liu ZY; Guo FP; Han Y; Qiu ZF; Zuo LY; Li YL; Li TS
    Chin Med J (Engl); 2009 Oct; 122(20):2497-502. PubMed ID: 20079166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
    McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
    Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventive antiretroviral therapy in non-thalassemia carrier infants exposed to mother-to-child transmission of HIV decreases cord and after delivery red blood production without altering the development of hemoglobin.
    Pornprasert S; Wongnoi R; Oberdorfer P; Sirivatanapa P
    Curr HIV Res; 2014; 12(3):227-31. PubMed ID: 25026900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly active antiretroviral therapy associated with improved anemia among HIV-infected women.
    Semba RD; Shah N; Klein RS; Mayer KH; Schuman P; Gardner LI; Vlahov D;
    AIDS Patient Care STDS; 2001 Sep; 15(9):473-80. PubMed ID: 11587633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.